Literature DB >> 1444642

Unusual rhombencephalitis in relapsing polychondritis.

J B Wasserfallen, M D Schaller.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1444642      PMCID： PMC1012441          DOI： 10.1136/ard.51.10.1184

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Relapsing polychondritis: audiovestibular manifestations.

Authors:  D T Cody; D A Sones
Journal:  Laryngoscope       Date:  1971-08       Impact factor: 3.325

2.  Idiopathic CSF pleocytosis in relapsing polychondritis.

Authors:  S Brod; J Booss
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

3.  Nervous system complications of relapsing polychondritis.

Authors:  M B Sundaram; A H Rajput
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

Review 4.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889
  4 in total
  3 in total

Review 1.  Rhombencephalitis / brainstem encephalitis.

Authors:  Burk Jubelt; Cornelia Mihai; Terrence M Li; Padma Veerapaneni
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

Review 2.  Relapsing polychondritis: a chameleon among orphan diseases.

Authors:  Sabine Schumacher; Herwig Pieringer
Journal:  Wien Med Wochenschr       Date:  2017-03-31

3.  Limbic encephalitis associated with relapsing polychondritis responded to infliximab and maintained its condition without recurrence after discontinuation: a case report and review of the literature.

Authors:  Takeshi Kondo; Mamiko Fukuta; Ayumu Takemoto; Yuichiro Takami; Motoki Sato; Noriyuki Takahashi; Tomio Suzuki; Juichi Sato; Naoki Atsuta; Gen Sobue; Yukitoshi Takahashi; Nobutaro Ban
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.